Zocdoc has 6 close competitors: Alloy Therapeutics, HistoSonics, Neuralink.
Sector, valuation and status for each competitor.
company profile›
competitor›
competitor›
competitor›
competitor›A private valuation and a public market cap share one column; each row names its basis and date.
ZocdocNeuralinkAbridgeCommureHeartFlowZocdoc operates an online platform for finding and booking in-person or telehealth medical and dental appointments, free for patients and monetized through provider subscriptions and referral fees.
Zocdoc competes with 6 companies here: Alloy Therapeutics, HistoSonics, Neuralink, Abridge, Commure, HeartFlow.
Zocdoc was last valued at $1.8B (post-money, Aug 2015). That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
The routes section explains what is realistically available for a company at this stage.
No. Zocdoc is a private company; its shares do not trade on a public exchange.
The last valuation is $1.8B.
Lead investors for each round are in the funding timeline.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
